cgp 42112a has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (1-methyl-3-isobutylxanthine) | Trials (1-methyl-3-isobutylxanthine) | Recent Studies (post-2010) (1-methyl-3-isobutylxanthine) |
---|---|---|---|---|---|
233 | 0 | 35 | 5,148 | 5 | 279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bottari, SP; Brechler, V; De Gasparo, M; Levens, NR | 1 |
1 other study(ies) available for cgp 42112a and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
Angiotensin AT2 receptor mediated inhibition of particulate guanylate cyclase: a link with protein tyrosine phosphatase stimulation?
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin II; Animals; Aorta; Arsenicals; Atrial Natriuretic Factor; Cell Membrane; Cells, Cultured; Cyclic GMP; GTP-Binding Proteins; Guanylate Cyclase; Muscle, Smooth, Vascular; Oligopeptides; PC12 Cells; Protein Tyrosine Phosphatases; Rats; Receptors, Angiotensin; Vanadates | 1994 |